Stockreport

Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212

Rallybio Corporation  (RLYB) 
PDF — Screening is Now Underway to Identify Pregnant Women at Higher Risk for HPA-1a Alloimmunization and FNAIT — NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation [Read more]